Helping patients safely navigate the complex cancer maze
Game-changing Cancer Breakthrough Keytruda | New immunotherapy drug now FDA approved Grace Gawler
Because of the immune system’s extraordinary power, its capacity for memory, its exquisite specificity, and its central and universal role in human biology, these immunotherapy treatments have the potential to achieve complete, long-lasting remissions and cancer cures, with few or no side effects, and for any cancer patient, regardless of their cancer type. ( CRI )
The Immune System and Cancer Control: Exciting Developments in the USA and at QIMR Berghofer Brisbane Australia…..
Keytruda (pembrolizumab) is made by the drug company Merck. The drug belongs to a class of immunotherapies called checkpoint inhibitors.These drugs “take the brakes off” the immune response to cancer. They represent the most promising new cancer therapies to emerge in decades. Merck’s drug is the first FDA approved checkpoint inhibitor targeting a molecule called PD-1. The drug has been approved for the treatment of advanced or inoperable melanoma in patients who have failed prior treatment.
For 60 years, Cancer Research Institute (CRI) has been the pioneer in advancing this highly promising new class of treatment. Because of this investment, cancer immunotherapy today is a highly active and exciting field, with unprecedented potential to deliver on the decades-long promise of discovering, developing, and delivering safe and effective treatments that make a meaningful difference in the lives of patients fighting the disease. For those living in the USA – if you want more information about checkpoint inhibitors and immunotherapies.
To Join a webinarpresented by Cancer Research Institute – “Immunotherapy: The Future of Prostate Cancer is Here”with Dr Charles Drake MD PhD September 30, 2014 at 2 pm ( please remember – New York time!) CLICK HERE
Because of the immune system’s extraordinary power, its capacity for memory, its exquisite specificity, and its central and universal role in human biology, these immunotherapy treatments have the potential to achieve complete, long-lasting remissions and cancer cures, with few or no side effects, and for any cancer patient, regardless of their cancer type.( CRI)
Please visit: www.cancerresearch.org for more more information about immunotherapy trials and treatments in USA.
In Queensland – Australia – QIMR Berghofer Medical Institute Brisbane is dedicated to translating discoveries into treatments, diagnostics and prevention strategies.
Listen to this interview with Sara-Jane who was a guest on Navigating the Cancer Maze Radio this week. Sara Jane is from QIMR Berghofer Medical Research Institute. She will speak about the Research Roadshow and other aspects of this research centre. Learn how you can get involved and benefit.
To discover what is being researched at QIMR visit their website by CLICKING HERE:
In Next blog:
More on the Research Roadshow at QIMR Berghofer and Record keeping – so important for any cancer patient. I look at some creative ways to keep your medical records in order.